On 9 February 2026, CF PharmTech, Inc. repurchased 1,500 H shares on the Hong Kong Stock Exchange at a highest price of HKD 35.12 and a lowest price of HKD 35.08 per share. The total repurchase amounted to HKD 52,650. These repurchased shares are held as treasury shares.

Following this repurchase, the number of issued shares (excluding treasury shares) stood at 302,010,086, while the total number of shares remained at 302,223,586. The total count of treasury shares reached 213,500. The repurchase was conducted under a mandate approved on 16 December 2025 that authorized up to 30,222,358 shares to be repurchased, representing 0.0706% of the issuer’s total number of issued shares (excluding treasury shares) as at the date of the mandate.